SINOVAC BIOTECH LTD: cashflow_financing
| Value | {"amount": -88554000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | SINOVAC BIOTECH LTD |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:46:16.563890+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fb63bbb7-06f9-4b83-b20d-46779b92915d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-194394Retrieved: 2026-08-19T10:46:16.563890+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001084201/cashflow-financing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fb63bbb7-06f9-4b83-b20d-46779b92915d
History
- supersedes {"amount": -76063000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0000950170-24-049936)